Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP: San Diego Monday, April 14, 2025, ...

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide ...

Halozyme Therapeutics, Inc. (Halozyme), a biotechnology company that pioneered the use of human hyaluronidase for subcutaneous drug delivery, today filed a patent infringement lawsuit against Merck ...

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide ...

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide ...

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide ...

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that ... Hylenex ® and XYOSTED ®, ...

XPENG’s humanoid robot, Iron, impresses at Auto Shanghai 2025 with human-like abilities, powered by XPENG's Turing AI chip ...

Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at its source.

JACKSONVILLE, Fla., April 02, 2025--(BUSINESS WIRE)--Proficient Auto Logistics (NASDAQ: PAL), a leading provider of auto transportation and logistics services, today announced the successful ...